Researcher Profiles

Return to member profile

John E. Langenfeld, MD

Publications since 2011

Augeri, D. J. Langenfeld, E. Castle, M. Gilleran, J. A. Langenfeld, J. Inhibition of BMP and of TGFbeta receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death. Mol Cancer, 15:27, . (PMID: 27048361, PMCID: PMC4822253)

Minerowicz, C. Jagpal, S. Uppaluri, L. Deen, M. Langenfeld, J. Calcifying Fibrous Pseudotumor of the Pleura. Am J Respir Crit Care Med, In process, . (PMID: 26266678)

Eng, O. S. Arlow, R. L. Moore, D. Chen, C. Langenfeld, J. E. August, D. A. Carpizo, D. R. Fluid administration and morbidity in transhiatal esophagectomy. J Surg Res, In process, . (PMID: 26319974)

Jabbour, S. K. Kim, S. Haider, S. A. Xu, X. Wu, A. Surakanti, S. Aisner, J. Langenfeld, J. Yue, N. J. Haffty, B. G. Zou, W. Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy. Int J Radiat Oncol Biol Phys, 92:627-633, . (PMID: 26068495)

Ahmed, I. Ferro, A. Cohler, A. Langenfeld, J. Surakanti, S. G. Aisner, J. Zou, W. Haffty, B. G. Jabbour, S. K. Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation. J Thorac Dis, 7:346-355, . (PMID: 25922712, PMCID: PMC4387400)

Narayanan, S. Sanders, R. L. Herlitz, G. Langenfeld, J. August, D. A. Treatment of Diaphragmatic Hernia Occurring After Transhiatal Esophagectomy. Ann Surg Oncol, In process, . (PMID: 25707490)

Arlow, R. L. Moore, D. F. Chen, C. Langenfeld, J. August, D. A. Outcome-volume relationships and transhiatal esophagectomy: minimizing "failure to rescue". Ann Surg Innov Res, 8:9, . (PMID: 25550708)

Langenfeld, E. Hong, C. C. Lanke, G. Langenfeld, J. Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines. PLoS One, 8:e61256, . (PMID: 23593444, PMCID: PMC3625205)

Langenfeld, E. Deen, M. Zachariah, E. Langenfeld, J. Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin. Mol Cancer, 12:129, . (PMID: 24160469)